Brief: Adicet Bio Q3 Basic EPS USD -0.29
05/11/2025 21:01
Nov 05 (Reuters) - Adicet Bio Q3 operating expenses USD 27.952 million. Q3 net income USD -26.856 million Q3 operating income USD -27.952 million
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary